Sacroplasty | Interventional Spine
Sacroplasty
A 2019 analysis suggests that sacroplasty is safe and effective for the treatment of sacral fractures caused by osteoporosis or cancer.3
How it works8
Before the procedure
Using x-ray guidance, one or more needles will be inserted into the sacrum through a small incision.
During the procedure
The sacrum is filled with bone cement to stabilize the fracture. As it hardens, the cement forms an internal cast that holds the sacrum in place. The incision will typically be covered with a bandage.
After the procedure
You will lie on your back for a short period of time while the cement continues to harden. Your blood pressure and pulse will be monitored before you go home. If you notice any signs of wound infection, bleeding, you should contact your healthcare provider immediately.
Tired of living in pain?
Let's find a doctor who can help.
Thank you!
Potential risks of the procedure
Serious side effects have been known to occur with the use of bone cement in surgical procedures of the spine. These include heart attack, cardiac arrest (heart stops beating), stroke, embolism (blood clot or bone cement that moves to the heart or lungs) or death. Side effects may occur up to one year after the procedure.9
Please consult with your doctor for the full list of possible side effects related to the use of bone cement.
The information presented is for educational purposes only. Stryker is not dispensing medical advice. Please speak to your doctor to decide what course of treatment is right for you. Only your doctor can make the medical judgment regarding which products and treatment is right for you. Any medical procedure carries certain risks and your doctor will explain all possible complications and/or side effects. Not all patients will experience the same results.
Stryker or its affiliated entities own, use or have applied for the following trademarks or service marks: AutoPlex, Dekompressor, Discmonitor, iVAS, mild, MultiGen, OmniCurve, OptaBlate, PCD, SpinePlex, SpineJack, Stryker, Venom, VertaPlex, VertaPlex HV, Verteport, and Verteport X4 Manifold. All other trademarks are trademarks of their respective owners or holders.
- Choi K et al. Effects of percutaneous sacroplasty on pain and mobility in sacral insufficiency fracture. Journal of Korean Neurosurgical Society. 2017; 60(1):60-66.
- Lee, Y. J., Bong, H. J., Kim, J. T., & Chung, D. S. (2008). Sacral insufficiency fracture, usually overlooked cause of lumbosacral pain. Journal of Korean Neurosurgical Society, 44(3), 166–169. https://doi.org/10.3340/jkns.2008.44.3.166
- Chandra V et al. Safety and efficacy of sacroplasty for sacral fractures: A systematic review and meta-analysis. Journal of Vascular and Interventional Radiology. 2019; 30(11):1845-1854.
- Mahmood B et al. Safety and efficacy of percutaneous sacroplasty for treatment of sacral insufficiency fractures: A systematic review. Journal of Spine Surgery. 2019; 5(3):365-371.
- Gupta A et al. Safety and effectiveness of sacroplasty: A large single-center experience. American Journal of Neuroradiology. 2014; 35(11):2202-2206.
- Kortman K et al. Multicenter study to assess the efficacy and safety of sacroplasty in patients with osteoporotic sacral insufficiency fractures or pathological sacral lesions. Journal of Neurointerventional Surgery. 2013; 5(5):461-466.
- Strub W et al. Sacroplasty by CT and fluoroscopic guidance: Is the procedure right for your patient? American Journal of Neuroradiology. 2007; 28(1):38-41.
- Stryker data on file.
- VertaPlex HV IFU (0406-622-715 Rev-AB)
IVS-GSNPS-MICRO-1695536_REV-0